Core Viewpoint - Amarin Corporation plc will report its third quarter 2025 financial results on October 29, 2025, followed by a conference call with senior management [1]. Group 1: Financial Reporting - The company will issue a press release detailing its third quarter 2025 financial results in the pre-market hours on October 29, 2025 [1]. - A conference call is scheduled for 8:00 a.m. ET on the same day to discuss the financial results [1]. Group 2: Participation Information - Investors can access the live call via telephone or online, with specific dial-in numbers provided for both U.S. and international participants [2]. - A replay of the conference call will be available shortly after the call and accessible until March 29, 2026 [2]. Group 3: Company Overview - Amarin is a global pharmaceutical company focused on reducing the burden of cardiovascular disease (CVD) and advancing cardiovascular care [3]. - The company has a global branded product approved by multiple regulatory authorities, supported by robust clinical trial evidence [3]. - Amarin employs a direct sales approach in the U.S. and an indirect distribution strategy internationally, covering over 90 markets worldwide [3].